Umbilical Cord Milking Versus Immediate Cord Clamping in Full Term Neonates (≥ 37 Weeks) Requiring Resuscitation

Sponsor
Lady Hardinge Medical College (Other)
Overall Status
Recruiting
CT.gov ID
NCT06090968
Collaborator
(none)
200
1
2
24
8.4

Study Details

Study Description

Brief Summary

The objective of the study is to compare the incidence of Hypoxic ischemic encephalopathy (all stages) among singleton term neonates (≥ 37 weeks) requiring resuscitation who will undergo Umbilical cord milking as compared to Immediate cord clamping.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Umbilical cord milking
  • Procedure: Immediate cord clamping
N/A

Detailed Description

Enrolled participants will be randomly allocated to one of two study groups: 1) Umbilical cord clamping, 2) Immediate cord clamping

Umbilical cord clamping group: In the babies requiring resuscitation during vaginal delivery, the delivering obstetrician will place the infant on the mother's abdomen and about 20 cm of umbilical cord would be milked towards the infant with intact umbilical cord. The cord milking will be done four times by the obstetrical provider or by a second team member at the rate of 20 cm/2 sec. This procedure can be done in 15-20 seconds. Length of 20 cm can be estimated by the length of a sponge holding forceps which is approximately 25 cm. The umbilical cord will then clamped 2 -3 cm from the umbilical stump.

Immediate cord clamping: This will occur by clamping the umbilical cord as soon as possible (average 30 seconds).

Further resuscitation will be done in accordance with NRP 2015 guidelines. Stop watch will be used to calculate the duration after which the cord is clamped and cut, time to first breath, and time required to achieve HR > 100/min

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Umbilical Cord Milking Versus Immediate Cord Clamping in Full Term Neonates (≥ 37 Weeks) Requiring Resuscitation - A RANDOMIZED CONTROL TRIAL
Actual Study Start Date :
Feb 5, 2022
Anticipated Primary Completion Date :
Dec 4, 2023
Anticipated Study Completion Date :
Feb 4, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Umbilical cord milking

20 cm of umbilical cord would be milked towards the infant with intact umbilical cord. The cord milking will be done four times. The entire procedure can be done in 15-20 seconds

Procedure: Umbilical cord milking
20 cm of umbilical cord would be milked towards the infant with intact umbilical cord. The cord milking will be done four times. The entire procedure can be done in 15-20 seconds

Active Comparator: Immediate cord clamping

clamping the umbilical cord as soon as possible (average 30 seconds)

Procedure: Immediate cord clamping
clamping the umbilical cord as soon as possible (average 30 seconds)

Outcome Measures

Primary Outcome Measures

  1. Incidence of Hypoxic Ischemic Encephalopathy [From date of birth until date of death from any cause whichever come first assessed till 1 week of life]

    any stage as per Sarnat and Sarnat Staging

Secondary Outcome Measures

  1. Proportion requiring NICU admission [Till 1 week of life]

    NICU admission due to any reason

  2. Level of hypoxic ischemic encephalopathy ( mild, moderate or severe) [From date of birth until date of death from any cause whichever come first assessed till 1 week of life]

    Level of hypoxic ischemic encephalopathy as per Sarnat and Sarnat Staging

  3. Received blood products or saline bolus or inotropes to support blood pressure [From date of birth until date of death from any cause whichever come first assessed till 1 week of life]

    Hypotension requiring blood products or saline bolus or inotropes

  4. Length of hospital stay [From date of birth until date of death from any cause whichever come first assessed till 4 week of life]

    Duration of stay in days

  5. Mean Blood Pressure at 2,6,12,24,48,72 hrs [From date of birth until date of death from any cause whichever come first assessed till 72 hours of life]

    Mean Blood Pressure as assessed by non-invasive oscillometric method

  6. Hyperbilirubinemia requiring phototherapy [From date of birth until date of death from any cause whichever come first assessed till 4 week of life]

    As per AAP charts

  7. Proportion of neonates having APGAR score < 4 at 5 minutes of life [Till 5 minutes of life]

    APGAR score (Min zero maximum Ten) assessed at 1,5 minutes (Low APGAR is bad prognosis and High APGAR is good prognosis)

  8. Neonates requiring Initial steps of resuscitation, Bag and Mask Ventilation, Intubation, chest compression and administration of drugs during resuscitation. [Till 1 minutes of life]

    As per NRP 2015 guidelines

  9. Proportion of neonates developing polycythemia [Till first 72 hours]

    Polycythemia is defined as venous hematocrit >65%

  10. Proportion of mortality due to any cause [From date of birth until date of death from any cause whichever come first assessed till 4 week of life]

    Including early and late neonatal deaths

Eligibility Criteria

Criteria

Ages Eligible for Study:
37 Weeks to 41 Weeks
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Vaginally born, Singleton Term gestation (≥ 37 and & < 42 weeks), requiring resuscitation at birth

Exclusion Criteria:
  • Major congenital anomaly (antenatally diagnosed or visible at birth)

  • Rh negative pregnancy

  • Hydrops

  • Abruptio Placneta/ Placenta previa

  • Fetus with absent and reversal of End Diastolic flow

  • Cord avulsion

  • Refusal of consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Lady Hardinge Medical college New Delhi Delhi India 110001

Sponsors and Collaborators

  • Lady Hardinge Medical College

Investigators

  • Study Chair: Sushma Nangia, DM (Neo), Lady Hardinge Medical College, New Delhi, India

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sushma Nangia, M.D., Dr. Sushma Nangia, Director Professor & Head, Department of Neonatology, Lady Hardinge Medical College
ClinicalTrials.gov Identifier:
NCT06090968
Other Study ID Numbers:
  • LHMC/IEC/071/UCM
First Posted:
Oct 19, 2023
Last Update Posted:
Oct 23, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 23, 2023